Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2794.05 and 2829.05
| Intraday Target 1 | 2786.83 |
| Intraday Target 2 | 2801.27 |
| Intraday Target 3 | 2821.8333333333 |
| Intraday Target 4 | 2836.27 |
| Intraday Target 5 | 2856.83 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 25 September 2026 | 2815.70 (-0.48%) | 2829.00 | 2807.40 - 2842.40 | 0.2666 times | Thu 24 September 2026 | 2829.20 (-1.66%) | 2874.00 | 2815.00 - 2880.00 | 0.3112 times | Wed 23 September 2026 | 2876.90 (0.11%) | 2859.60 | 2839.90 - 2922.00 | 2.8946 times | Tue 22 September 2026 | 2873.60 (0.37%) | 2862.70 | 2840.00 - 2880.90 | 0.643 times | Mon 21 September 2026 | 2862.90 (0.85%) | 2837.00 | 2835.70 - 2875.10 | 0.3783 times | Fri 18 September 2026 | 2838.80 (1.39%) | 2800.00 | 2800.00 - 2900.00 | 2.1711 times | Thu 17 September 2026 | 2799.90 (-1.97%) | 2852.00 | 2794.50 - 2862.30 | 0.4981 times | Wed 16 September 2026 | 2856.20 (1.32%) | 2818.00 | 2755.90 - 2878.00 | 1.4812 times | Tue 15 September 2026 | 2818.90 (-0.34%) | 2814.90 | 2775.80 - 2840.80 | 0.69 times | Fri 11 September 2026 | 2828.40 (-0.44%) | 2840.90 | 2793.90 - 2863.50 | 0.666 times | Thu 10 September 2026 | 2840.90 (-1.71%) | 2934.80 | 2832.20 - 2961.80 | 0.6683 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2754.25 and 2868.85
| Weekly Target 1 | 2733.77 |
| Weekly Target 2 | 2774.73 |
| Weekly Target 3 | 2848.3666666667 |
| Weekly Target 4 | 2889.33 |
| Weekly Target 5 | 2962.97 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 25 September 2026 | 2815.70 (-0.81%) | 2837.00 | 2807.40 - 2922.00 | 0.4543 times | Fri 18 September 2026 | 2838.80 (0.37%) | 2814.90 | 2755.90 - 2900.00 | 0.4893 times | Fri 11 September 2026 | 2828.40 (-4.38%) | 2937.90 | 2793.90 - 3075.00 | 0.5474 times | Fri 04 September 2026 | 2958.10 (-4.77%) | 3106.50 | 2908.50 - 3120.00 | 0.804 times | Fri 28 August 2026 | 3106.40 (7.04%) | 2875.10 | 2865.40 - 3120.70 | 1.2805 times | Fri 21 August 2026 | 2902.20 (7.94%) | 2688.00 | 2660.00 - 3054.90 | 4.0779 times | Fri 14 August 2026 | 2688.80 (3.43%) | 2595.80 | 2576.10 - 2697.00 | 0.4947 times | Fri 07 August 2026 | 2599.70 (-2.1%) | 2665.40 | 2515.00 - 2684.00 | 0.5531 times | Fri 31 July 2026 | 2655.40 (5.61%) | 2524.00 | 2494.10 - 2679.00 | 0.7289 times | Fri 24 July 2026 | 2514.30 (2.42%) | 2454.50 | 2445.40 - 2570.00 | 0.5699 times | Fri 17 July 2026 | 2454.80 (0.68%) | 2439.90 | 2406.30 - 2527.00 | 0.7179 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2626.25 and 2945.35
| Monthly Target 1 | 2563.1 |
| Monthly Target 2 | 2689.4 |
| Monthly Target 3 | 2882.2 |
| Monthly Target 4 | 3008.5 |
| Monthly Target 5 | 3201.3 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 25 September 2026 | 2815.70 (-7.68%) | 3040.00 | 2755.90 - 3075.00 | 0.5722 times | Mon 31 August 2026 | 3050.10 (14.86%) | 2665.40 | 2515.00 - 3120.70 | 2.0014 times | Fri 31 July 2026 | 2655.40 (8.37%) | 2476.80 | 2370.00 - 2679.00 | 0.8787 times | Tue 30 June 2026 | 2450.30 (10.86%) | 2200.00 | 2088.10 - 2460.90 | 1.5793 times | Fri 29 May 2026 | 2210.20 (-5.4%) | 2342.00 | 2194.40 - 2520.00 | 1.0942 times | Thu 30 April 2026 | 2336.40 (2.34%) | 2305.00 | 2261.90 - 2529.90 | 0.674 times | Mon 30 March 2026 | 2283.00 (-11.22%) | 2520.00 | 2217.60 - 2581.60 | 0.5431 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.7924 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.7079 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.1569 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 0.9649 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2451.9 and 3484.5
| Yearly Target 1 | 1642.23 |
| Yearly Target 2 | 2228.97 |
| Yearly Target 3 | 2674.8333333333 |
| Yearly Target 4 | 3261.57 |
| Yearly Target 5 | 3707.43 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 25 September 2026 | 2815.70 (13.83%) | 2476.00 | 2088.10 - 3120.70 | 0.8932 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.471 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.1008 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.1678 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.6783 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9048 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0097 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4319 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2197 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1228 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1231 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in downtrend.
But this trend seems to be weakening.Price is below an important level of 2857.05 on charts, and if price remains below this level, then stock might show a fall in short term.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Munafa value: 40 as on Fri 25 September 2026
This Munafa value indicates that the stock is moving downwards and might continue to move down.
SMA20 is at 2901 and price is deviating by 82 points
Upper Bollinger band is at 3063 and lower is at 2739, while middle bands are at 2820 and 2982
Price is coming down
Price is below 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for GlaxosmithklinePharmaceuticals in short term but the sell signal is initial and weak.
GlaxosmithklinePharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2850.64 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2851.66 |
| 12 day DMA | 2844.3 |
| 20 day DMA | 2900.79 |
| 35 day DMA | 2865.95 |
| 50 day DMA | 2776.99 |
| 100 day DMA | 2555.66 |
| 150 day DMA | 2517.55 |
| 200 day DMA | 2506.28 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2839.59 | 2851.53 | 2862.69 |
| 12 day EMA | 2857.05 | 2864.56 | 2870.99 |
| 20 day EMA | 2860.62 | 2865.35 | 2869.15 |
| 35 day EMA | 2810.67 | 2810.37 | 2809.26 |
| 50 day EMA | 2758.45 | 2756.11 | 2753.13 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2851.66 | 2856.28 | 2850.42 |
| 12 day SMA | 2844.3 | 2853.68 | 2864.39 |
| 20 day SMA | 2900.79 | 2913.46 | 2923.72 |
| 35 day SMA | 2865.95 | 2859.2 | 2851.79 |
| 50 day SMA | 2776.99 | 2770.8 | 2763.89 |
| 100 day SMA | 2555.66 | 2551.14 | 2546.35 |
| 150 day SMA | 2517.55 | 2516.09 | 2514.53 |
| 200 day SMA | 2506.28 | 2504.76 | 2503.2 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 61.15 and PE is: 46.05
Last quarter profit: (March 2026 quarter) 277.86 crores (5.70%)
Debt: 33.27 in crores
Market capitalization: 39891.73
EPS is 60.27 and PE is: 46.72
Last quarter profit: (December 2025 quarter) 295.62 crores (22.82%)
Debt: 35.71 in crores
Market capitalization: 38277.29
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
